| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.37 | 8e-07 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-05 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-05 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-05 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.31 | 5e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.2 | 5e-05 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |